Join
Live feed
·
INSIDERFilingvia Quantisnow
Actinium Pharmaceuticals Inc. (Delaware) logo

Chief Executive Officer Seth Sandesh was granted 1,780,874 shares, increasing direct ownership by 965% to 1,965,355 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATNM· Actinium Pharmaceuticals Inc. (Delaware)
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATNM (Actinium Pharmaceuticals Inc. (Delaware)) and more on Quantisnow.